Medtronic has been dealt a setback in efforts to win U.S. Food and Drug Administration approval of its Amplify, what it consider a new innovative medical device for the spine. The news came on the same day Medtronic launched its Atlantis Vision Elite Anterior Cervical Plate System in the United States.
The Food & Drug Administration wants more information on possibly elevated cancer risks from Medtronic Inc.’s Amplify spinal implant. The Food & Drug Administration wants more answers about possibly elevated cancer risks from Medtronic Inc.’s (NYSE:MDT) Amplify spinal implant, which uses a bone morphogenic protein to stimulate bone growth. The federal watchdog agency will ask […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.